<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Posterior Reversible Encephalopathy Syndrome (PRES) Infographic</title>
    <script src="https://cdn.tailwindcss.com"></script>
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;600;700;900&display=swap" rel="stylesheet">
    <style>
        body {
            font-family: 'Inter', sans-serif;
        }
        .gradient-text {
            background: linear-gradient(to right, #67e8f9, #0ea5e9);
            -webkit-background-clip: text;
            -webkit-text-fill-color: transparent;
        }
        .stat-bar-bg {
            background-color: #374151; /* gray-700 */
        }
        .stat-bar {
            background: linear-gradient(to right, #38bdf8, #0ea5e9);
        }
        .section-icon {
            stroke: #0ea5e9;
        }
    </style>
</head>
<body class="bg-slate-900 text-gray-300 antialiased">

    <div class="container mx-auto p-4 sm:p-6 lg:p-8">

        <!-- Header -->
        <header class="text-center mb-10">
            <h1 class="text-3xl sm:text-4xl lg:text-5xl font-extrabold text-white tracking-tight">Posterior Reversible Encephalopathy Syndrome <span class="gradient-text">(PRES)</span></h1>
            <p class="mt-2 text-lg text-slate-400">A Guide to Clinicoradiological Findings</p>
        </header>

        <main class="grid grid-cols-1 md:grid-cols-2 lg:grid-cols-3 gap-6">

            <!-- I. General MRI Characteristics & Edema Type -->
            <div class="bg-slate-800/50 backdrop-blur-sm rounded-xl p-6 lg:col-span-3 border border-slate-700">
                <div class="flex items-center mb-4">
                    <svg class="h-8 w-8 section-icon mr-3" xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 24 24" stroke-width="1.5" stroke="currentColor">
                        <path stroke-linecap="round" stroke-linejoin="round" d="M9.813 15.904L9 18.75l-.813-2.846a4.5 4.5 0 00-3.09-3.09L2.25 12l2.846-.813a4.5 4.5 0 003.09-3.09L9 5.25l.813 2.846a4.5 4.5 0 003.09 3.09L15.75 12l-2.846.813a4.5 4.5 0 00-3.09 3.09zM18.259 8.715L18 9.75l-.259-1.035a3.375 3.375 0 00-2.455-2.456L14.25 6l1.036-.259a3.375 3.375 0 002.455-2.456L18 2.25l.259 1.035a3.375 3.375 0 002.456 2.456L21.75 6l-1.035.259a3.375 3.375 0 00-2.456 2.456zM16.898 20.648l.21-1.05a2.25 2.25 0 00-1.58-2.618l-1.05-.21a2.25 2.25 0 00-2.618 1.58l-.21 1.05a2.25 2.25 0 001.58 2.618l1.05.21a2.25 2.25 0 002.618-1.58z" />
                    </svg>
                    <h2 class="text-xl font-bold text-white">I. General MRI Characteristics & Edema</h2>
                </div>
                <p class="mb-4 text-slate-400">PRES is characterized by <span class="text-sky-400 font-semibold">reversible cortico-subcortical hyperintensities</span> on T2/FLAIR images, indicating vasogenic edema.</p>
                <div class="grid grid-cols-1 sm:grid-cols-2 gap-4">
                    <div>
                        <h3 class="font-semibold text-white">Vasogenic Edema (Typical)</h3>
                        <ul class="list-disc list-inside text-sm text-slate-400 mt-1 space-y-1">
                            <li>High ADC values</li>
                            <li>Iso- or hypointense on DWI</li>
                            <li>May show T2 shine-through effect on DWI</li>
                        </ul>
                    </div>
                    <div>
                        <h3 class="font-semibold text-white">Cytotoxic Edema (Less Common)</h3>
                        <ul class="list-disc list-inside text-sm text-slate-400 mt-1 space-y-1">
                            <li>Bright signal on DWI</li>
                            <li>Decreased ADC values</li>
                            <li>Correlates with larger vasogenic edema areas</li>
                        </ul>
                    </div>
                </div>
                <div class="mt-6">
                    <h3 class="font-semibold text-white mb-2">Edema Composition (Study of 79 Patients)</h3>
                    <div class="space-y-3">
                        <div>
                            <div class="flex justify-between mb-1">
                                <span class="text-sm font-medium text-sky-400">Pure Vasogenic Edema</span>
                                <span class="text-sm font-medium text-white">67.09%</span>
                            </div>
                            <div class="w-full stat-bar-bg rounded-full h-2.5">
                                <div class="stat-bar h-2.5 rounded-full" style="width: 67.09%"></div>
                            </div>
                        </div>
                        <div>
                            <div class="flex justify-between mb-1">
                                <span class="text-sm font-medium text-amber-400">Vasogenic + Cytotoxic Components</span>
                                <span class="text-sm font-medium text-white">32.91%</span>
                            </div>
                            <div class="w-full stat-bar-bg rounded-full h-2.5">
                                <div class="bg-amber-500 h-2.5 rounded-full" style="width: 32.91%"></div>
                            </div>
                        </div>
                    </div>
                </div>
            </div>

            <!-- II. Lesion Location & Distribution -->
            <div class="bg-slate-800/50 backdrop-blur-sm rounded-xl p-6 lg:col-span-2 border border-slate-700">
                <div class="flex items-center mb-4">
                    <svg class="h-8 w-8 section-icon mr-3" xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 24 24" stroke-width="1.5" stroke="currentColor">
                        <path stroke-linecap="round" stroke-linejoin="round" d="M12 9.75v6.75m0 0l-3-3m3 3l3-3m-8.25 6a4.5 4.5 0 01-1.41-8.775 5.25 5.25 0 0110.233-2.33 3 3 0 013.758 3.848A3.752 3.752 0 0118 19.5H6.75z" />
                    </svg>
                    <h2 class="text-xl font-bold text-white">II. Lesion Location & Distribution</h2>
                </div>
                <div class="space-y-4">
                    <div>
                        <h3 class="font-semibold text-sky-400">Typical Pattern: Posterior Dominance</h3>
                        <p class="text-sm text-slate-400">Predominantly affects subcortical white matter of posterior lobes. Usually symmetrical and bilateral.</p>
                        <div class="flex flex-wrap gap-4 mt-2">
                            <div class="text-center">
                                <p class="text-2xl font-bold text-white">~100%</p>
                                <p class="text-xs text-slate-500">Parietal Lobe</p>
                            </div>
                            <div class="text-center">
                                <p class="text-2xl font-bold text-white">~85%</p>
                                <p class="text-xs text-slate-500">Occipital Lobe</p>
                            </div>
                        </div>
                    </div>
                    <div>
                        <h3 class="font-semibold text-amber-400">Atypical Locations (Common)</h3>
                        <p class="text-sm text-slate-400">Involvement is not restricted to posterior regions.</p>
                        <ul class="mt-2 space-y-2 text-sm">
                            <li class="flex items-center">
                                <span class="font-semibold text-white w-28">Frontal Lobes:</span>
                                <div class="w-full stat-bar-bg rounded-full h-2.5 ml-2"><div class="stat-bar h-2.5 rounded-full" style="width: 78.3%"></div></div>
                                <span class="text-xs text-white ml-2">~78%</span>
                            </li>
                             <li class="flex items-center">
                                <span class="font-semibold text-white w-28">Temporal Lobes:</span>
                                <div class="w-full stat-bar-bg rounded-full h-2.5 ml-2"><div class="stat-bar h-2.5 rounded-full" style="width: 45.57%"></div></div>
                                <span class="text-xs text-white ml-2">~46%</span>
                            </li>
                            <li class="flex items-center">
                                <span class="font-semibold text-white w-28">Cerebellum:</span>
                                <div class="w-full stat-bar-bg rounded-full h-2.5 ml-2"><div class="stat-bar h-2.5 rounded-full" style="width: 37.97%"></div></div>
                                <span class="text-xs text-white ml-2">~38%</span>
                            </li>
                            <li class="flex items-center">
                                <span class="font-semibold text-white w-28">Basal Ganglia:</span>
                                <div class="w-full stat-bar-bg rounded-full h-2.5 ml-2"><div class="stat-bar h-2.5 rounded-full" style="width: 27.85%"></div></div>
                                <span class="text-xs text-white ml-2">~28%</span>
                            </li>
                            <li class="flex items-center">
                                <span class="font-semibold text-white w-28">Brain Stem:</span>
                                <div class="w-full stat-bar-bg rounded-full h-2.5 ml-2"><div class="stat-bar h-2.5 rounded-full" style="width: 18.99%"></div></div>
                                <span class="text-xs text-white ml-2">~19%</span>
                            </li>
                             <li class="flex items-center">
                                <span class="font-semibold text-white w-28">Corpus Callosum:</span>
                                <div class="w-full stat-bar-bg rounded-full h-2.5 ml-2"><div class="stat-bar h-2.5 rounded-full" style="width: 13%"></div></div>
                                <span class="text-xs text-white ml-2">~13%</span>
                            </li>
                        </ul>
                    </div>
                </div>
            </div>

            <!-- III. Atypical Imaging Features -->
            <div class="bg-slate-800/50 backdrop-blur-sm rounded-xl p-6 border border-slate-700">
                <div class="flex items-center mb-4">
                     <svg class="h-8 w-8 section-icon mr-3 text-amber-500" xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 24 24" stroke-width="1.5" stroke="currentColor">
                        <path stroke-linecap="round" stroke-linejoin="round" d="M12 9v3.75m-9.303 3.376c-.866 1.5.217 3.374 1.948 3.374h14.71c1.73 0 2.813-1.874 1.948-3.374L13.949 3.378c-.866-1.5-3.032-1.5-3.898 0L2.697 16.126zM12 15.75h.007v.008H12v-.008z" />
                    </svg>
                    <h2 class="text-xl font-bold text-white">III. Atypical Imaging Features</h2>
                </div>
                <div class="space-y-5">
                    <div>
                        <h3 class="font-semibold text-amber-400">Contrast Enhancement</h3>
                        <p class="text-sm mt-1 text-slate-400">Seen in <span class="text-white font-bold">21-50%</span> of patients. Does not correlate with functional outcome.</p>
                    </div>
                    <div>
                        <h3 class="font-semibold text-amber-400">Hemorrhage</h3>
                        <p class="text-sm mt-1 text-slate-400">Occurs in <span class="text-white font-bold">5-30%</span> of cases and doesn't exclude PRES. Can be intraparenchymal, microbleeds, or subarachnoid.</p>
                    </div>
                    <div>
                        <h3 class="font-semibold text-amber-400">Restricted Diffusion</h3>
                        <p class="text-sm mt-1 text-slate-400">Indicates cytotoxic edema. Found in <span class="text-white font-bold">17-33%</span> of cases. Can lead to permanent injury.</p>
                    </div>
                </div>
            </div>

            <!-- IV. Resolution and Prognosis -->
            <div class="bg-slate-800/50 backdrop-blur-sm rounded-xl p-6 md:col-span-1 lg:col-span-2 border border-slate-700">
                 <div class="flex items-center mb-4">
                    <svg class="h-8 w-8 section-icon mr-3" xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 24 24" stroke-width="1.5" stroke="currentColor">
                        <path stroke-linecap="round" stroke-linejoin="round" d="M19.5 12c0-1.232-.046-2.453-.138-3.662a4.006 4.006 0 00-3.7-3.7 48.678 48.678 0 00-7.324 0 4.006 4.006 0 00-3.7 3.7c-.092 1.21-.138 2.43-.138 3.662v1.562a4.006 4.006 0 003.7 3.7c1.846.053 3.695.085 5.568 0a4.006 4.006 0 003.7-3.7v-1.562z" />
                        <path stroke-linecap="round" stroke-linejoin="round" d="M12 15.75a3 3 0 01-3-3h6a3 3 0 01-3 3z" />
                    </svg>
                    <h2 class="text-xl font-bold text-white">IV. Resolution & Prognosis</h2>
                </div>
                <p class="text-slate-400 mb-4">While PRES is typically <span class="text-sky-400 font-semibold">reversible</span>, it's not always complete. Follow-up imaging is crucial.</p>
                <div class="bg-slate-900/50 p-4 rounded-lg">
                    <h3 class="font-semibold text-white">Resolution Timeline</h3>
                    <p class="text-sm text-slate-400">Median time for MRI lesion improvement/disappearance: <span class="text-white font-bold">9 days</span> (range 3-60 days).</p>
                    <p class="text-sm text-slate-400 mt-1"><span class="text-white font-bold">~40%</span> may have residual structural lesions on follow-up.</p>
                </div>
                <div class="mt-4 bg-red-900/20 border border-red-500/30 p-4 rounded-lg">
                    <h3 class="font-semibold text-red-300">Features Associated with Poor Outcomes</h3>
                     <ul class="list-disc list-inside text-sm text-red-300/80 mt-2 space-y-1">
                        <li>Extensive or worsening edema</li>
                        <li>Intracranial / Subarachnoid hemorrhage</li>
                        <li>Restrictive diffusion (cytotoxic edema)</li>
                        <li>Corpus callosum involvement</li>
                    </ul>
                </div>
            </div>

            <!-- V. Diagnostic Considerations -->
            <div class="bg-slate-800/50 backdrop-blur-sm rounded-xl p-6 md:col-span-1 lg:col-span-1 border border-slate-700">
                 <div class="flex items-center mb-4">
                    <svg class="h-8 w-8 section-icon mr-3" xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 24 24" stroke-width="1.5" stroke="currentColor">
                        <path stroke-linecap="round" stroke-linejoin="round" d="M21 21l-5.197-5.197m0 0A7.5 7.5 0 105.196 5.196a7.5 7.5 0 0010.607 10.607z" />
                    </svg>
                    <h2 class="text-xl font-bold text-white">V. Diagnostic Considerations</h2>
                </div>
                <div class="space-y-4">
                    <div>
                        <h3 class="font-semibold text-white">MRI vs. CT</h3>
                        <p class="text-sm text-slate-400">MRI is more sensitive/specific. CT is often the first test and may show hypodense areas (92.3% in one pediatric study).</p>
                    </div>
                    <div>
                        <h3 class="font-semibold text-white">Differential Diagnosis</h3>
                        <p class="text-sm text-slate-400"><span class="font-bold text-sky-400">Acute Ischemic Stroke:</span> Typically shows cytotoxic edema (restricted diffusion) in a unilateral vascular territory.</p>
                        <div class="mt-2">
                            <p class="text-sm text-slate-400"><span class="font-bold text-sky-400">PRES & RCVS Overlap:</span> These syndromes often overlap. RCVS involves multifocal narrowing of cerebral arteries.</p>
                            <ul class="list-disc list-inside text-sm text-slate-400/90 mt-1 pl-2 space-y-1">
                                <li>PRES occurs in <span class="text-white font-semibold">9-38%</span> of RCVS cases.</li>
                                <li><span class="text-white font-semibold">87%</span> of PRES cases show angiographic changes consistent with RCVS.</li>
                            </ul>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- VI. Sources -->
            <div class="bg-slate-800/50 backdrop-blur-sm rounded-xl p-6 lg:col-span-3 border border-slate-700">
                <div class="flex items-center mb-4">
                    <svg class="h-8 w-8 section-icon mr-3" xmlns="http://www.w3.org/2000/svg" fill="none" viewBox="0 0 24 24" stroke-width="1.5" stroke="currentColor">
                        <path stroke-linecap="round" stroke-linejoin="round" d="M12 6.042A8.967 8.967 0 006 3.75c-1.052 0-2.062.18-3 .512v14.25A8.987 8.987 0 016 18c2.305 0 4.408.867 6 2.292m0-14.25a8.966 8.966 0 016-2.292c1.052 0 2.062.18 3 .512v14.25A8.987 8.987 0 0018 18a8.967 8.967 0 00-6 2.292m0-14.25v14.25" />
                    </svg>
                    <h2 class="text-xl font-bold text-white">VI. Sources</h2>
                </div>
                <ul class="space-y-3 text-xs text-slate-400">
                    <li>Aracki-Trenkić, A., et al. (2016). Atypical presentation of posterior reversible encephalopathy syndrome... <em>Bosnian Journal of Basic Medical Sciences, 16</em>(3), 180–186. <a href="https://doi.org/10.17305/bjbms.2016.1201" class="text-sky-500 hover:underline" target="_blank">https://doi.org/10.17305/bjbms.2016.1201</a></li>
                    <li>Anderson, R.-C., et al. (2020). Posterior Reversible Encephalopathy Syndrome (PRES): Pathophysiology and Neuro-Imaging. <em>Frontiers in Neurology, 11</em>, 463. <a href="https://doi.org/10.3389/fneur.2020.00463" class="text-sky-500 hover:underline" target="_blank">https://doi.org/10.3389/fneur.2020.00463</a></li>
                    <li>Behera, C. K., et al. (2020). Clinico-radiological Profile of Posterior Reversible Encephalopathy Syndrome... <em>Indian Journal of Critical Care Medicine, 24</em>(12), 1223–1229. <a href="https://doi.org/10.5005/jp-journals-10071-23680" class="text-sky-500 hover:underline" target="_blank">https://doi.org/10.5005/jp-journals-10071-23680</a></li>
                    <li>Cui, H.-W., et al. (2022). Clinical Features and Risk Factors of Mortality in Patients with Posterior Reversible Encephalopathy Syndrome. <em>BioMed Research International, 2022</em>, 9401661. <a href="https://doi.org/10.1155/2022/9401661" class="text-sky-500 hover:underline" target="_blank">https://doi.org/10.1155/2022/9401661</a></li>
                    <li>Gao, B., et al. (2015). Cytotoxic Edema in Posterior Reversible Encephalopathy Syndrome... <em>American Journal of Neuroradiology, 36</em>(10), 1884–1889. <a href="https://doi.org/10.3174/ajnr.A4379" class="text-sky-500 hover:underline" target="_blank">https://doi.org/10.3174/ajnr.A4379</a></li>
                    <li>Posterior Reversible Encephalopathy Syndrome (PRES). (2016, December 22). <em>American Journal of Neuroradiology</em>. Retrieved from <a href="https://www.ajnr.org/page/PRES" class="text-sky-500 hover:underline" target="_blank">https://www.ajnr.org/page/PRES</a></li>
                    <li>Triplett, J. D., et al. (2022). Posterior reversible encephalopathy syndrome (PRES): diagnosis and management. <em>Practical Neurology, 22</em>(3), 183–189. <a href="https://doi.org/10.1136/practneurol-2021-003194" class="text-sky-500 hover:underline" target="_blank">https://doi.org/10.1136/practneurol-2021-003194</a></li>
                </ul>
            </div>

        </main>

        <footer class="text-center mt-10 text-xs text-slate-500">
            <p>This infographic summarizes key clinicoradiological findings of PRES based on current literature.</p>
            <p>For educational purposes only. Not a substitute for professional medical advice.</p>
        </footer>

    </div>

</body>
</html>
